|Articles|February 9, 2022
- Pharmaceutical Executive-02-01-2022
- Volume 42
- Issue 2
Pharmaceutical Executive, February 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive February 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 4 years ago
As Change Continues, Are You Digitally Fit For the Future?about 4 years ago
Ready for Pharma’s Next Chapterabout 4 years ago
The Tech Perspective: Coordinating a Plan of Engagementabout 4 years ago
The Importance of Culturally Inclusive and Relevant Marketingabout 4 years ago
Messaging Makeoverabout 4 years ago
Ethics of Antibioticsabout 4 years ago
What’s Up in Biotech These Days? Not Much, Unfortunatelyabout 4 years ago
Planning for Second to Market in Orphan Disease Spaceabout 4 years ago
AI and Analytics Appear Ready to Surge in Sales and Marketingabout 4 years ago
It’s Time for Companies To See Employees as Full-Time PeopleNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Travere Therapeutics’ Filspari Receives Full FDA Approval
2
Regeneron Enters $2.1 Billion Radiopharma Collaboration with Telix Pharmaceuticals
3
FDA Issues CRL to Replimune for RP1 Biologics License Application for Advanced Melanoma Treatment
4
Managing Patient Experience and RWE in Clinical Trials: Q&A with Matt Holms, MB
5